Simplex Trading, LLC Galectin Therapeutics Inc Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 9,790 shares of GALT stock, worth $26,628. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,790
Previous 11,354 13.77%
Holding current value
$26,628
Previous $25,000 4.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$2.04 - $2.86 $3,190 - $4,473
-1,564 Reduced 13.77%
9,790 $26,000
Q2 2024

Jul 25, 2024
BUY
$2.13 - $4.2 $7,406 - $14,603
3,477 Added 44.14%
11,354 $25,000
Q1 2024

Apr 25, 2024
BUY
$1.6 - $2.44 $1,467 - $2,237
917 Added 13.18%
7,877 $18,000
Q4 2023

Feb 02, 2024
SELL
$1.6 - $2.18 $5,979 - $8,146
-3,737 Reduced 34.94%
6,960 $11,000
Q3 2023

Nov 01, 2023
BUY
$1.38 - $1.97 $2,598 - $3,709
1,883 Added 21.36%
10,697 $20,000
Q2 2023

Aug 04, 2023
BUY
$1.32 - $2.08 $1,078 - $1,699
817 Added 10.22%
8,814 $12,000
Q1 2023

Apr 27, 2023
SELL
$1.1 - $2.4 $12,898 - $28,142
-11,726 Reduced 59.45%
7,997 $16,000
Q4 2022

Feb 02, 2023
BUY
$1.03 - $1.66 $9,571 - $15,426
9,293 Added 89.1%
19,723 $22,000
Q3 2022

Nov 04, 2022
SELL
$1.31 - $2.48 $22,847 - $43,253
-17,441 Reduced 62.58%
10,430 $17,000
Q2 2022

Aug 03, 2022
BUY
$1.19 - $1.74 $17,766 - $25,978
14,930 Added 115.37%
27,871 $36,000
Q1 2022

May 02, 2022
BUY
$1.61 - $2.31 $13,902 - $19,946
8,635 Added 200.53%
12,941 $20,000
Q4 2021

Feb 23, 2022
BUY
$2.07 - $3.8 $8,913 - $16,362
4,306 New
4,306 $8,000
Q2 2021

Aug 12, 2021
SELL
$2.07 - $5.1 $8,093 - $19,941
-3,910 Closed
0 $0
Q1 2021

Apr 26, 2021
BUY
$1.96 - $2.57 $7,547 - $9,897
3,851 Added 6527.12%
3,910 $8,000
Q4 2020

Feb 02, 2021
BUY
$2.24 - $2.87 $132 - $169
59 New
59 $0
Q2 2020

Jul 13, 2020
SELL
$1.66 - $3.15 $2,895 - $5,493
-1,744 Closed
0 $0
Q1 2020

Apr 29, 2020
BUY
$1.51 - $3.0 $2,633 - $5,232
1,744 New
1,744 $3,000
Q3 2019

Oct 15, 2019
SELL
$3.0 - $4.05 $2,958 - $3,993
-986 Closed
0 $0
Q2 2019

Jul 26, 2019
BUY
$3.61 - $5.0 $3,559 - $4,930
986 New
986 $4,000
Q1 2019

Apr 18, 2019
SELL
$3.86 - $6.02 $29,826 - $46,516
-7,727 Closed
0 $0
Q4 2018

Jan 16, 2019
BUY
$3.43 - $5.74 $14,433 - $24,153
4,208 Added 119.58%
7,727 $26,000
Q3 2018

Oct 23, 2018
BUY
$3.68 - $6.93 $12,949 - $24,386
3,519 New
3,519 $21,000
Q2 2018

Jul 30, 2018
SELL
$3.16 - $9.16 $4,155 - $12,045
-1,315 Closed
0 $0
Q1 2018

Apr 26, 2018
SELL
$3.78 - $5.97 $13,967 - $22,059
-3,695 Reduced 73.75%
1,315 $6,000
Q4 2017

Jan 10, 2018
SELL
$1.54 - $3.34 $36,462 - $79,081
-23,677 Reduced 82.54%
5,010 $16,000
Q3 2017

Oct 25, 2017
BUY
$1.67 - $2.3 $47,907 - $65,980
28,687
28,687 $61,000

Others Institutions Holding GALT

# of Institutions
90
Shares Held
9.57M
Call Options Held
1.16M
Put Options Held
1.98M
View Full List

About GALECTIN THERAPEUTICS INC

GALT Quotes by TradingView
  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $162M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email